BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17048213)

  • 1. Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome.
    Vezzoli G; Arcidiacono T; Paloschi V; Terranegra A; Biasion R; Weber G; Mora S; Syren ML; Coviello D; Cusi D; Bianchi G; Soldati L
    J Nephrol; 2006; 19(4):525-8. PubMed ID: 17048213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant hypocalcemia in monozygotic twins caused by a de novo germline mutation near the amino-terminus of the human calcium receptor.
    Hu J; Mora S; Weber G; Zamproni I; Proverbio MC; Spiegel AM
    J Bone Miner Res; 2004 Apr; 19(4):578-86. PubMed ID: 15005845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome.
    Vargas-Poussou R; Huang C; Hulin P; Houillier P; Jeunemaître X; Paillard M; Planelles G; Déchaux M; Miller RT; Antignac C
    J Am Soc Nephrol; 2002 Sep; 13(9):2259-66. PubMed ID: 12191970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Pidasheva S; D'Souza-Li L; Canaff L; Cole DE; Hendy GN
    Hum Mutat; 2004 Aug; 24(2):107-11. PubMed ID: 15241791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia.
    Hirai H; Nakajima S; Miyauchi A; Nishimura K; Shimizu N; Shima M; Michigami T; Ozono K; Okada S
    J Hum Genet; 2001; 46(1):41-4. PubMed ID: 11289719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914.
    Park SY; Mun HC; Eom YS; Baek HL; Jung TS; Kim CH; Hong S; Lee S
    Clin Endocrinol (Oxf); 2013 May; 78(5):687-93. PubMed ID: 23009664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemia.
    Letz S; Haag C; Schulze E; Frank-Raue K; Raue F; Hofner B; Mayr B; Schöfl C
    PLoS One; 2014; 9(12):e115178. PubMed ID: 25506941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three novel activating mutations in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia.
    Conley YP; Finegold DN; Peters DG; Cook JS; Oppenheim DS; Ferrell RE
    Mol Genet Metab; 2000 Dec; 71(4):591-8. PubMed ID: 11136551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel calcium-sensing receptor gene mutation causing familial hypocalciuric hypercalcemia by single-strand conformation polymorphism analysis.
    Felderbauer P; Hoffmann P; Klein W; Bulut K; Ansorge N; Epplen JT; Schmitz F; Schmidt WE
    Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):31-4. PubMed ID: 15662592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism.
    Hannan FM; Thakker RV
    Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):359-71. PubMed ID: 23856265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
    Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal dominant hypocalcemia with Bartter syndrome due to a novel activating mutation of calcium sensing receptor, Y829C.
    Choi KH; Shin CH; Yang SW; Cheong HI
    Korean J Pediatr; 2015 Apr; 58(4):148-53. PubMed ID: 25932037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new missense mutation of calcium sensing receptor with isoleucine replaced by serine at codon 857 leading to type V Bartter syndrome.
    Chou KJ; Hsu CY; Huang CW; Chen HJ; Ou SH; Chen CL; Lee PT; Fang HC
    Exp Cell Res; 2022 May; 414(1):113080. PubMed ID: 35192837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).
    Dong B; Endo I; Ohnishi Y; Kondo T; Hasegawa T; Amizuka N; Kiyonari H; Shioi G; Abe M; Fukumoto S; Matsumoto T
    J Bone Miner Res; 2015 Nov; 30(11):1980-93. PubMed ID: 25967373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia.
    Kinoshita Y; Hori M; Taguchi M; Watanabe S; Fukumoto S
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E363-8. PubMed ID: 24297799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome.
    Watanabe S; Fukumoto S; Chang H; Takeuchi Y; Hasegawa Y; Okazaki R; Chikatsu N; Fujita T
    Lancet; 2002 Aug; 360(9334):692-4. PubMed ID: 12241879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia.
    Okazaki R; Chikatsu N; Nakatsu M; Takeuchi Y; Ajima M; Miki J; Fujita T; Arai M; Totsuka Y; Tanaka K; Fukumoto S
    J Clin Endocrinol Metab; 1999 Jan; 84(1):363-6. PubMed ID: 9920108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CASR gene activating mutations in two families with autosomal dominant hypocalcemia.
    Guarnieri V; Valentina D'Elia A; Baorda F; Pazienza V; Benegiamo G; Stanziale P; Copetti M; Battista C; Grimaldi F; Damante G; Pellegrini F; D'Agruma L; Zelante L; Carella M; Scillitani A
    Mol Genet Metab; 2012 Nov; 107(3):548-52. PubMed ID: 22789683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation of the primary protein kinase C phosphorylation site in the calcium-sensing receptor causes autosomal dominant hypocalcemia.
    Lazarus S; Pretorius CJ; Khafagi F; Campion KL; Brennan SC; Conigrave AD; Brown EM; Ward DT
    Eur J Endocrinol; 2011 Mar; 164(3):429-35. PubMed ID: 21135065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia - a German survey.
    Raue F; Pichl J; Dörr HG; Schnabel D; Heidemann P; Hammersen G; Jaursch-Hancke C; Santen R; Schöfl C; Wabitsch M; Haag C; Schulze E; Frank-Raue K
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):760-5. PubMed ID: 21645025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.